Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011
by Taipei Medical University WanFang Hospital.
Recruitment status was Recruiting
Study NCT01300637 Information provided by Taipei Medical University WanFang Hospital
First Received on February 17, 2011. Last Updated on February 18, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Metabolic Syndrome
Schizophrenia
Additional conditions recognized in this trial
Metabolic Syndrome X
More general conditions related to this trial
Body Weight
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Mental Disorders
Metabolic Diseases
Nutrition Disorders
Overnutrition
Overweight
Schizophrenia and Disorders with Psychotic Features
Signs and Symptoms
Interventions listed in this trial
Metformin
placebo
Additional drug interventions recognized in this trial
Clozapine
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Antagonists
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Taipei Medical University WanFang Hospital
National Science Council, Taiwan
Back to top of Main Content
